# Advances in neuropsychiatry: From objective diagnostics to mechanism-based therapeutics

**Authors:** Andrew A. Pieper, Francis S. Lee

PMC · DOI: 10.1016/j.neurot.2026.e00854 · 2026-02-17

## Full-text entities

- **Genes:** MAPT (microtubule associated protein tau) [NCBI Gene 4137] {aka DDPAC, FTD1, FTDP-17, MAPTL, MSTD, MTBT1}, FAAH (fatty acid amide hydrolase) [NCBI Gene 2166] {aka FAAH-1, FAAH1, PSAB}, MGLL (monoglyceride lipase) [NCBI Gene 11343] {aka HU-K5, HUK5, MAGL, MGL}, CNR1 (cannabinoid receptor 1) [NCBI Gene 1268] {aka CANN6, CB-R, CB1, CB1A, CB1K5, CB1R}
- **Diseases:** neuropsychiatric complications (MESH:D008107), binge-eating disorder (MESH:D056912), ASD (MESH:D000067877), SUD (MESH:D019966), Mental illness (MESH:D001523), AD (MESH:D000544), autism (MESH:D001321), anorexia (MESH:D000855), Schizophrenia (MESH:D012559), neuroinflammation (MESH:D000090862), delirium (MESH:D003693), Major depression (MESH:D003865), PTS (MESH:C535325), bulimia nervosa (MESH:D052018), agitation (MESH:D011595), neuropsychiatric (MESH:C000631768), psychosis (MESH:D011618), bulimia (MESH:D002032), depression (MESH:D003866), Bipolar and personality disorders (MESH:D001714), anorexia nervosa (MESH:D000856), ARFID (MESH:D000080146), disordered eating (MESH:D001068), HIV (MESH:D015658)
- **Chemicals:** trospium chloride (MESH:C003330), anandamide (MESH:C078814), xanomeline (MESH:C075257), AEA (-), 2-AG (MESH:C094503), cocaine (MESH:D003042), fluoxetine (MESH:D005473), eCB (MESH:D063388), lisdexamfetamine (MESH:D000069478)
- **Species:** Human immunodeficiency virus 1 (no rank) [taxon 11676], Human immunodeficiency virus (species) [taxon 12721], Homo sapiens (human, species) [taxon 9606]

---
Source: https://tomesphere.com/paper/PMC12976510